ANTIBIOTIC RESISTANCE IN NEISSERIA GONORRHOEAE – PAST, PRESENT AND FUTURE

  • Ermelindo Tavares Interno do Internato Complementar de Dermatologia e Venereologia/Resident Dermatology and Venereology, Hospital Distrital de Santarém EPE, Santarém, Portugal
  • Cândida Fernandes Assistente Graduada de Dermatologia e Venereologia/Graduated Consultant of Dermatology and Venereology, Consulta de Doenças Sexualmente Transmissíveis/STDs Clinic, Serviço de Dermatologia e Venereologia, Hospital de Curry Cabral, Centro Hospitalar de Lisboa Central, EPE, Lisboa, Portugal
  • Maria José Borrego Coordenadora do Laboratório Nacional de Referência das Infeções Sexualmente Transmissíveis/Coordinator of the National Laboratory of Sexual Transmitted Infections, Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisboa, Portugal
  • Ana Rodrigues Assistente Graduada de Dermatologia e Venereologia/Graduated Consultant of Dermatology and Venereology, Consulta de Doenças Sexualmente Transmissíveis/STDs Clinic, Serviço de Dermatologia e Venereologia, Hospital de Curry Cabral, Centro Hospitalar de Lisboa Central, EPE, Lisboa, Portugal
  • Jorge Cardoso Diretor do Serviço de Dermatologia e Venereologia/Director of the Dermatology and Venereology Department, Hospital de Curry Cabral, Centro Hospitalar de Lisboa Central, EPE, Lisboa, Portugal

Abstract

Introduction: The antibiotic resistance in Neisseria gonorrhoeae has been considered an important public health problem worldwide, posing serious problems for its treatment in some countries. Aims: To overview the national and international antibiotic resistance reports on Neisseria gonorrhoeae. Material and Methods: Literature search in national and international scientific journals (the later indexed in PubMed/Medline and in English language). "Neis- seria gonorrhoeae antibiotic resistance" were used as keywords. Results: Third-generation cephalosporins (ceftriaxone and cefixime), alone or combined with azithromycin, replaced fluroquinolones as the first-line treatment for gonorrhea. Up to now, there were just a few reports on cephalosporin resistance. However, reports of an increase of the minimum inhibitory concentration (MIC) to cephalosporins, reflected by the decreased sensitivity to this class of antibiotics, be- came frequent. The azithromycin resistance has been reported in several countries. In Portugal, to date, there are no described cases of cephalosporin resistance; however, azithromycin – resistant Neisseria gonorrhoeae isolates and re- duced sensitivity to cephalosporins have already been described. Conclusion: New therapeutic agents are essential to overcome antibiotic resistance in Neisseria gonorrhoeae, as well as appropriate conducts by physicians, patients and sexual contacts of the later.

KEYWORDS – Anti-Bacterial agents; Drug resistance, bacterial; Neisseria gonorrhoeae; Guideline. 

Downloads

Download data is not yet available.
Published
2013-04-20
How to Cite
Tavares, E., Fernandes, C., Borrego, M. J., Rodrigues, A., & Cardoso, J. (2013). ANTIBIOTIC RESISTANCE IN NEISSERIA GONORRHOEAE – PAST, PRESENT AND FUTURE. Journal of the Portuguese Society of Dermatology and Venereology, 70(4), 483-493. https://doi.org/10.29021/spdv.70.4.102
Section
Grupo para o Estudo e Investigação das Doenças Sexualmente Transmissíveis (GEIDS